Philip Astley-Sparke - Executive Chairman, Director at Replimune Group, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Director
Stock Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Philip Astley-Sparke - trading volume in the past year for Replimune Group, Inc.

Holdings reported by Philip Astley-Sparke for Replimune Group, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 1,487,350 $9.62 M $6.47 May 16, 2024 Direct

Transactions reported by Philip Astley-Sparke for Replimune Group, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership